INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2013
Total net assets |
£154.4m |
NAV per share |
279.9p |
Share price |
227.0p |
Total value of unquoted investments |
£25.7m |
Total number of portfolio companies |
70 |
Cash |
0.5% NAV |
Cash committed and reserved to unquoted investments |
(5.2)% NAV |
Portfolio companies with < 1 year of cash |
14.06% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Celgene Gilead |
8.3 7.4 6.3 |
Onyx |
5.2 |
Aptiv |
3.8 |
Celldex |
3.2 |
Insulet |
3.2 |
Alexion |
3.1 |
Actelion |
2.6 |
Biomarin |
2.5 |
|
----------- |
Total |
45.6 |
Geographical Allocation |
% |
United States & Canada |
88 |
Europe |
10 |
Australia |
1 |
Cash |
1 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
83 |
Unquoted |
16 |
Cash |
1 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 APRIL 2013